annual total liabilities:
$46.81M-$78.44M(-62.63%)Summary
- As of today (May 29, 2025), SMMT annual total liabilities is $46.81 million, with the most recent change of -$78.44 million (-62.63%) on December 31, 2024.
- During the last 3 years, SMMT annual total liabilities has risen by +$16.72 million (+55.57%).
- SMMT annual total liabilities is now -91.29% below its all-time high of $537.51 million, reached on December 31, 2022.
Performance
SMMT Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$39.49M-$7.32M(-15.64%)Summary
- As of today (May 29, 2025), SMMT quarterly total liabilities is $39.49 million, with the most recent change of -$7.32 million (-15.64%) on March 31, 2025.
- Over the past year, SMMT quarterly total liabilities has dropped by -$93.08 million (-70.21%).
- SMMT quarterly total liabilities is now -92.65% below its all-time high of $537.51 million, reached on December 31, 2022.
Performance
SMMT quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SMMT Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.6% | -70.2% |
| 3 y3 years | +55.6% | -24.1% |
| 5 y5 years | +169.3% | +85.0% |
SMMT Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.3% | +55.6% | -92.7% | +78.9% |
| 5 y | 5-year | -91.3% | +169.3% | -92.7% | +97.4% |
| alltime | all time | -91.3% | >+9999.0% | -92.7% | >+9999.0% |
SMMT Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $39.49M(-15.6%) |
| Dec 2024 | $46.81M(-62.6%) | $46.81M(-27.9%) |
| Sep 2024 | - | $64.93M(-55.8%) |
| Jun 2024 | - | $146.78M(+10.7%) |
| Mar 2024 | - | $132.57M(+5.8%) |
| Dec 2023 | $125.26M(-76.7%) | $125.26M(+5.2%) |
| Sep 2023 | - | $119.10M(+1.1%) |
| Jun 2023 | - | $117.77M(-3.0%) |
| Mar 2023 | - | $121.42M(-77.4%) |
| Dec 2022 | $537.51M(+1686.4%) | $537.51M(+2334.5%) |
| Sep 2022 | - | $22.08M(-50.3%) |
| Jun 2022 | - | $44.40M(-14.7%) |
| Mar 2022 | - | $52.06M(+73.0%) |
| Dec 2021 | $30.09M(+30.6%) | $30.09M(+14.1%) |
| Sep 2021 | - | $26.38M(+1.1%) |
| Jun 2021 | - | $26.09M(-65.8%) |
| Mar 2021 | - | $76.39M(+231.5%) |
| Dec 2020 | $23.05M(+32.6%) | - |
| Dec 2020 | - | $23.05M(+15.2%) |
| Sep 2020 | - | $20.00M(-6.3%) |
| Mar 2020 | - | $21.35M(+32.5%) |
| Dec 2019 | $17.39M(-26.8%) | - |
| Oct 2019 | - | $16.11M(-10.0%) |
| Jul 2019 | - | $17.90M(-7.8%) |
| Apr 2019 | - | $19.41M(-18.2%) |
| Jan 2019 | $23.74M(-71.2%) | - |
| Jan 2019 | - | $23.74M(+11.2%) |
| Oct 2018 | - | $21.34M(+18.4%) |
| Jul 2018 | - | $18.02M(-77.4%) |
| Apr 2018 | - | $79.81M(-3.3%) |
| Jan 2018 | $82.56M(+60.8%) | - |
| Jan 2018 | - | $82.56M(+91.9%) |
| Oct 2017 | - | $43.03M(-13.1%) |
| Jul 2017 | - | $49.50M(-1.6%) |
| Apr 2017 | - | $50.28M(-2.1%) |
| Jan 2017 | $51.35M | - |
| Jan 2017 | - | $51.35M(+0.4%) |
| Oct 2016 | - | $51.12M(+852.7%) |
| Jul 2016 | - | $5.37M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2016 | - | $5.66M(-55.7%) |
| Jan 2016 | $12.79M(+31.9%) | - |
| Jan 2016 | - | $12.79M(+134.8%) |
| Oct 2015 | - | $5.44M(+3.1%) |
| Jul 2015 | - | $5.28M(+0.1%) |
| Apr 2015 | - | $5.28M(-45.6%) |
| Jan 2015 | $9.69M(+132.0%) | - |
| Jan 2015 | - | $9.69M(+65.7%) |
| Oct 2014 | - | $5.85M(+1.8%) |
| Jul 2014 | - | $5.75M(+37.5%) |
| Jan 2014 | $4.18M(+73.3%) | - |
| Jan 2014 | - | $4.18M(+87.8%) |
| Jul 2013 | - | $2.22M(-7.7%) |
| Jan 2013 | $2.41M(+3.0%) | - |
| Jan 2013 | - | $2.41M(+124.0%) |
| Jul 2012 | - | $1.08M(-54.0%) |
| Jan 2012 | $2.34M(+4.6%) | - |
| Jan 2012 | - | $2.34M(-31.5%) |
| Jul 2011 | - | $3.42M(+52.7%) |
| Jan 2011 | $2.24M(-56.6%) | - |
| Jan 2011 | - | $2.24M(-51.2%) |
| Jul 2010 | - | $4.59M(-11.0%) |
| Jan 2010 | $5.15M(-33.6%) | - |
| Jan 2010 | - | $5.15M(-3.1%) |
| Jul 2009 | - | $5.32M(-31.5%) |
| Jan 2009 | $7.77M(-49.2%) | - |
| Jan 2009 | - | $7.77M(-48.9%) |
| Jul 2008 | - | $15.20M(-0.7%) |
| Jan 2008 | $15.30M(+141.8%) | - |
| Jan 2008 | - | $15.30M(+10.3%) |
| Jul 2007 | - | $13.88M(+119.3%) |
| Jan 2007 | $6.33M(+153.9%) | - |
| Jan 2007 | - | $6.33M(+257.3%) |
| Jul 2006 | - | $1.77M(-28.9%) |
| Jan 2006 | $2.49M(+611.6%) | - |
| Jan 2006 | - | $2.49M(+155.5%) |
| Jul 2005 | - | $975.40K(+178.5%) |
| Jan 2005 | $350.20K | - |
| Jan 2005 | - | $350.20K(+64.3%) |
| Jul 2004 | - | $213.20K |
FAQ
- What is Summit Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Summit Therapeutics?
- What is Summit Therapeutics annual total liabilities year-on-year change?
- What is Summit Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Summit Therapeutics?
- What is Summit Therapeutics quarterly total liabilities year-on-year change?
What is Summit Therapeutics annual total liabilities?
The current annual total liabilities of SMMT is $46.81M
What is the all time high annual total liabilities for Summit Therapeutics?
Summit Therapeutics all-time high annual total liabilities is $537.51M
What is Summit Therapeutics annual total liabilities year-on-year change?
Over the past year, SMMT annual total liabilities has changed by -$78.44M (-62.63%)
What is Summit Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SMMT is $39.49M
What is the all time high quarterly total liabilities for Summit Therapeutics?
Summit Therapeutics all-time high quarterly total liabilities is $537.51M
What is Summit Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SMMT quarterly total liabilities has changed by -$93.08M (-70.21%)